Since 2003, researchers have noticed that scientists tend to study the same genes, over and over. And the genes that become popular aren't necessarily the most interesting ones, they say. It may be decades before all the genes are studied.
An analysis of nearly 4,000 mutations deliberately engineered into the BRCA1 gene will immediately benefit people undergoing genetic testing for breast or ovarian cancer risk.
